Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of $44.8 billion as of February 3, 2026. Its market cap has increased by 39.41% in one year.

• Market Cap: 44.80B
• Enterprise Value: 44.85B
• 1-Year Change: 39.41%
• Ranking: #330
• Category: Large-Cap
• Stock Price: $339.11

Market Cap Chart

Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $44.80B, an increase of 33,086.01%. That is a compound annual growth rate of 30.69%.

Market Cap History

Date	Market Cap	% Change
Feb 2, 2026	44.80B	-14.72%
Dec 31, 2025	52.54B	73.09%
Dec 31, 2024	30.35B	26.35%
Dec 29, 2023	24.02B	-17.84%
Dec 30, 2022	29.24B	44.16%
Dec 31, 2021	20.28B	34.32%
Dec 31, 2020	15.10B	17.60%
Dec 31, 2019	12.84B	74.32%
Dec 31, 2018	7.37B	-37.48%
Dec 29, 2017	11.78B	266.69%
Dec 30, 2016	3.21B	-59.72%
Dec 31, 2015	7.98B	6.90%
Dec 31, 2014	7.46B	82.96%
Dec 31, 2013	4.08B	326.36%
Dec 31, 2012	956.60M	174.73%
Dec 30, 2011	348.20M	-16.32%
Dec 31, 2010	416.10M	-43.53%
Dec 31, 2009	736.80M	-28.05%
Dec 31, 2008	1.02B	-13.48%
Dec 31, 2007	1.18B	71.64%
Dec 29, 2006	689.60M	94.42%
Dec 30, 2005	354.70M	136.47%
Dec 31, 2004	150.00M	11.11%
Jun 1, 2004	135.00M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Vertex Pharmaceuticals	119.76B
Regeneron Pharmaceuticals	77.46B
argenx SE	51.55B
BeOne Medicines AG	38.18B
Insmed	32.84B
BioNTech SE	27.32B
Royalty Pharma	24.45B
Genmab	20.35B